API Sulfonate Salts Why draw attention to these versions of APIs?

A concern from a regulatory stance, BP and Ph. Er., with progressing a potential drug molecule sulfonate salt into clinical and drug development is the formation and presence of mutagenic alkyl sulfonate impurities produced when the salt formation or salt recrystallisation was conducted in alcohol solvents.